Four novel mutations identification in 17 beta-hydroxysteroid dehydrogenase-3 deficiency and our clinical experience: possible benefits of early treatment

Four novel mutations identification in 17 beta-hydroxysteroid dehydrogenase-3 deficiency and our clinical experience: possible benefits of early treatment

IntroductionIndividuals with 17-beta-hydroxysteroid dehydrogenase type 3 (17β-HSD3) deficiency face a multitude of challenges, primarily concerning genital appearance, potential malignancy risks, and fertility issues. This study reports our findings from an investigation involving five individuals a...

Full description

Bibliographic Details
Main Authors: Yunpeng Wang, Yu Xu, Huijiao Zhang, Danyang Yin, Yiming Pan, Xiwen He, Shuaiting Li, Zhi Cheng, Gaohui Zhu, Ting Zhao, Huizhe Huang, Min Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Endocrinology
Subjects:
17β-HSD3 deficiency
HSD17B3
mutation
malignancy risk
androgen
testosterone
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1267967/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1267967/full

Similar Items